期刊文献+

Alpha-tubulin deacetylase as a potential and novel target for the prevention of Parkinson's disease progression

Alpha-tubulin deacetylase as a potential and novel target for the prevention of Parkinson's disease progression
下载PDF
导出
摘要 Parkinson's disease (PD) is the second most common neurodegenerative disorder and is characterized by its progressive course. The current therapies are aimed at alleviating symptoms by rescuing the unbalanced physiological dopamine metabolism and recovery of damaged neuronal circuits. However, these strategies result in insufficient clinical benefits for many patients and fail to halt disease progression. Therefore, new therapeutic targets could serve as the gateway against PD degeneration. One pathological hallmark of PD is the formation of intracytoplasmic protein inclusions or Lewy bodies, in neurons. Recent studies have suggested that Lewy bodies are formed similarly to aggresomes, and results have supported the concept that the novel cellular organelle, the aggresome, is a cytoprotective response that sequesters and facilitates clearance of potentially toxic protein aggregates. In addition, a-tubulin deacetylase has been shown to regulate aggresome formation and rescue neural cell viability in response to misfolded protein. Therefore, the regulation of aggresome formation to trigger cellular self-protection system could arrest PD progression. The present study discusses research progress related to Lewy bodies, aggresomes, and histone deacetylases, with an emphasis on histone deacetylase 6 and sirtuin type 2. Parkinson's disease (PD) is the second most common neurodegenerative disorder and is characterized by its progressive course. The current therapies are aimed at alleviating symptoms by rescuing the unbalanced physiological dopamine metabolism and recovery of damaged neuronal circuits. However, these strategies result in insufficient clinical benefits for many patients and fail to halt disease progression. Therefore, new therapeutic targets could serve as the gateway against PD degeneration. One pathological hallmark of PD is the formation of intracytoplasmic protein inclusions or Lewy bodies, in neurons. Recent studies have suggested that Lewy bodies are formed similarly to aggresomes, and results have supported the concept that the novel cellular organelle, the aggresome, is a cytoprotective response that sequesters and facilitates clearance of potentially toxic protein aggregates. In addition, a-tubulin deacetylase has been shown to regulate aggresome formation and rescue neural cell viability in response to misfolded protein. Therefore, the regulation of aggresome formation to trigger cellular self-protection system could arrest PD progression. The present study discusses research progress related to Lewy bodies, aggresomes, and histone deacetylases, with an emphasis on histone deacetylase 6 and sirtuin type 2.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2011年第2期131-135,共5页 中国神经再生研究(英文版)
关键词 Parkinson's disease Lewy body AGGRESOME histone deacetylases a-tubulin deacetylase mini review neural regeneration Parkinson's disease Lewy body aggresome histone deacetylases a-tubulin deacetylase mini review neural regeneration
  • 相关文献

参考文献62

  • 1de Lau LM,Breteler MM.Epidemiology of Parkinson's disease.Lancet Neurol.2006;5:525-535.
  • 2Tanner CM,Goldman SM.Epidemiology of Parkinson's disease.Neurol Clin.1996;14:317-335.
  • 3Ahlskog JE,Muenter MD.Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature.Mov Disord.2001;16:448-458.
  • 4Hely MA,Morris JG,Reid WG,et al.The Sydney Murticentre Study of Parkinson's disease:a randomised,prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.J Neurol Neurosurg Psychiatry.1994;57:903-910.
  • 5Koller WC,Hutton JT,Tolosa E,et al.Immediate-release and controlled-release carbidopa/levodopa in PD:a 5-year randomized multicenter study.Carbidopa/Levodopa Study Group.Neurology.1999;53:1012-1019.
  • 6Samii A,Nutt JG Ransom BR.Parkinson's disease.Lancet.2004;363:1783-1793.
  • 7Braak H,Del Tredici K,Rüb U,et al.Staging of brain pathology related to sporadic Parkinson's disease.Neurobiol Aging.2003;24:197-211.
  • 8Forno LS.Neuropathology of Parkinson's disease.J Neuropathol Exp Neurol.1996;55:259-272.
  • 9Tu PH,Gurney ME,Julien JP,et al.Oxidative stress,mutant SOD1,and neurofilament pathology in transgenic mouse models of human motor neuron disease.Lab Invest.1997;76:441-456.
  • 10Tu PH,Robinson KA,de Snoo F,et al.Selective degeneration fo Purkinje cells with Lewy body-like inclusions in aged NFHLACZ transgenic mice.J Neurosci.1997; 17:1064-1074.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部